PeptideStack
5.2kquestions
20kanswers
220users

How does JEEP compare to Shanghai ERP Biotechnology on documentation quality?

Asked 1 Mar 2026Modified 39 days agoViewed 5.5k times
4

Conditions: JEEP · Shanghai ERP Biotechnology.

I have used one of these for a while and I am considering switching, which requires a reason.

What I care about is reproducibility, because a result I cannot repeat is not useful to me.

So which one, and on what grounds?

vendor-comparison
vendor-comparison

Side-by-side comparison of suppliers on measurable axes - independently confirmed purity and content, lead time, cold-chain handling,…

388 questions
coa
coa

Certificates of analysis: what fields a useful one carries, how to tell a real analytical report from a marketing document, batch and lot…

771 questions
vendor-vetting
vendor-vetting

Evaluating a supplier on evidence rather than reputation: testing history across batches, whether certificates are batch-specific, how failures…

454 questions
shareeditfollowflag
VF
askedvial_five12k171 Mar 2026
Is this about one lot or about a supplier across lots? Different questions. – dead_volume 3 months ago
add a comment

5 Answers

Sorted by votes
19

Answer first: comparing suppliers is only meaningful if the comparison holds the laboratory, the method and the compound constant, and most published comparisons hold none of them.

To compare properly: order the same compound at the same nominal strength from each supplier, submit all samples to the same laboratory in the same submission if possible, and ask for the same test set on each.

Cost per milligram, adjusted honestly

StepValueNote
Vial price, 10 mg nominal£34.00As advertised
Nominal cost per mg£3.4034 ÷ 10
Measured content9.2 mgIndependent content assay
Cost per actual mg£3.7034 ÷ 9.2
Dead-space loss, 20 draws4 %80 µL of a 2 mL fill
Cost per delivered mg£3.853.70 ÷ 0.96
First vial, with £110 assay£14.85Testing dominates a single vial

The relevant detail is that content is the more discriminating measurement than purity for supplier comparison, because purity clusters tightly among competent suppliers and content does not.

Content assay results across the published datasets vary considerably more between suppliers than purity does, which makes content the more discriminating axis.

One laboratory, one method, one submission. Otherwise it is not a comparison.

shareimprove this answerflag
TM
answeredtobias_maartens171k35823 May 2026
Sponsored

Janoshik Analytical - Independent Third-Party Testing

HPLC purity, identity confirmation and quantified content on the vial you actually hold. Reports arrive with the chromatogram attached, not just a number.

Submit a sample
Sponsored — paired listing

GL Biochem (Shanghai) Ltd. - Direct Synthesis

Founded 1998. ISO 9001 and cGMP certified, 1,500+ staff and 200+ patents. The synthesis house behind a great many of the vials that get sent out for testing - batch-specific documentation with every order.

Visit GL Biochem
15

The short version: same compound, same laboratory, same method, ideally same week — otherwise you are comparing laboratories rather than suppliers.

Cost per milligram of actual peptide is the honest price comparison, which means dividing by measured content rather than by label claim.

Worth being precise here: publish the method with the result. A comparison without the laboratory named and the submission dates given is not reproducible by anyone.

Gradient slope, column chemistry and detection wavelength all affect the reported purity figure, which is why the method section is the part that makes results comparable.

Name the laboratory and the dates or the comparison cannot be reproduced.

edited 21 Jun 2026 by a_lindgren — added the method parameters

shareimprove this answerflag
AL
answereda_lindgren58k2484 Jun 2026
13

Start by asking what you are optimising for, because cost per milligram, documentation depth and lead time do not have a common winner.

Lead time and lane behaviour are supplier properties too and are easier to compare than analytical ones, because they need no laboratory at all.

Compare documentation on a fixed checklist rather than by impression: lot specificity, method section, chromatogram availability, quantified content, water and counter-ion figures, and whether the code is on the vial.

Inter-laboratory spread on identical peptide material is routinely half a per cent to a per cent by RP-HPLC, which is the noise floor for any cross-laboratory comparison.

Compare content, not purity. Purity clusters and content does not.

shareimprove this answerflag
NK
answerednadia_kowalczyk20k2812 May 2026
7Is there a sensible order size where independent testing stops being a large surcharge? – linnea_wahlberg 4 months ago
8Worth flagging that comparing across laboratories is comparing laboratories, not suppliers. – nine_point_nine 5 months ago
add a comment
10

The honest answer is that most claimed differences between reputable suppliers are inside inter-laboratory noise.

Sample size matters. One order each is an anecdote about six vials; three orders each over a year is the beginning of a comparison.

Comparisons drawn from different laboratories at different times are weaker evidence than most people treat them as.

Use a fixed documentation checklist rather than an impression.

shareimprove this answerflag
PM
answeredp_mkhize58k23815 Jun 2026
5

Mechanically, this is the question where methodology matters more than the conclusion.

Submitting to different laboratories introduces a method difference that commonly exceeds the supplier difference. Gradient slope alone can move a reported purity figure by a per cent in either direction.

No supplier on this site pays for its position, and the storefront links are marked nofollow and sponsored.

Price per milligram of measured peptide, not per milligram of label claim.

shareimprove this answerflag
VF
answeredvial_five12k179 Mar 2026
6Does the same reasoning hold for a group order, where one lot covers everybody? – colm_dunphy 7 months ago
add a comment

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.